This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
At the April meeting of the American Rhinologic Society, Palm Beach, Fla, Murray Sacks, MD, Rochester, Minn, presented his work on the use of topical and systemic steroids in the treatment of nasal disorders. Sacks classified rhinitis into three types: allergic, nonallergic with eosinophilia, and nonallergic without eosinophilia (vasomotor rhinitis). Earlier double-blind cross-over studies from The Johns Hopkins University, Baltimore, demonstrated the efficacy of both topical beclomethasone and flunisolide in the treatment of allergic rhinitis. The prolonged use of topical nasal steroid therapy appears to be safe. The primary local complication is burning, a problem more frequent with flunisolide. Other local complications, such as epistaxis, may be seen occasionally, but other complications are rare when the medications are used at the recommended doses. Systemic effects have not been observed.
A previous study of nonallergic rhinitis with eosinophilia demonstrated that 52% of these patients have sinusitis and 33% have nasal polyps.
KENNEDY DW. The Use of Topical and Systemic Steroids in the Treatment of Nasal Disorders. Arch Otolaryngol Head Neck Surg. 1989;115(1):11. doi:10.1001/archotol.1989.01860250013004
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: